Kazia Therapeutics Limited (KZIA) Stock Forecast
KZIA analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.67 / 5 from 6 analysts
- Price target
- $28.21 average of analyst targets
- Upside to target
- +289.2% from the latest close
- Next earnings
- November 6, 2026
- 52-week range
- $5.00 – $16.90
KZIA analyst ratings
6 analystsNumber of analysts at each rating.
KZIA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
KZIA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (FY2027) | −$0.02 | −$0.02 | −$0.02 | −$0.02 | −4.3% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
KZIA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (FY2027) | $642,000 | $0 | $2.9M | −5.2% | 5 |
KZIA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
KZIA revenue: reported and forecast
KZIA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (FY2027) | −$0.02 | −$0.02 | −$0.02 | −$0.02 | −$0.02 | −21.9% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
KZIA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; KZIA beat in 1 of 12.
What analysts expect from KZIA
6 analysts cover Kazia Therapeutics; their consensus rating is strong buy (4.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $28.21, 289.2% above the latest close of $7.25. For FY2027 the average estimate is −$0.02 per share on revenue of $0.6 million. Kazia Therapeutics beat the EPS estimate in 1 of the last 12 quarters.
Related: KZIA income statement, KZIA key metrics, KZIA chart. See the KZIA stock overview for the latest quote and news.
KZIA forecast FAQ
What is Kazia Therapeutics's price target?
The average analyst price target for Kazia Therapeutics is $28.21, 289.2% above the latest close of $7.25.
Is Kazia Therapeutics a buy, hold or sell?
Of 6 analysts covering Kazia Therapeutics, 4 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
When does Kazia Therapeutics report earnings?
Kazia Therapeutics is expected to report results for the quarter ending September 30, 2026 on November 6, 2026.
Does Kazia Therapeutics usually beat earnings estimates?
Kazia Therapeutics reported EPS at or above the analyst estimate in 1 of the last 12 quarters.